VCYT insider filings

VERACYTE, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-29. Screen VCYT transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 13 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Holstein Jens — Director2—3 legs · 20,000 sh · $932,2474
EASTHAM KARIN — Director1—1 leg · 14,850 sh · $742,5732
Febbo Phillip G. — Chief Scientific & Med Officer1—2 legs · 13,110 sh · $564,4101
Bhanji Muna — Director2—2 legs · 3,728 sh · $161,553—
Leite John — Global Chief Commercial Off2—1 leg · 4,015 sh · $160,6001
Chambers Rebecca — Chief Financial Officer1—2 legs · 3,652 sh · $157,3941
McGuire Annie — EVP, General Counsel1—2 legs · 3,254 sh · $140,2121
Wygant Jonathan — VP, Chief Accounting Officer2——2
Stapley Marc — Chief Executive Officer, Director1——1

Recent insider filings — VERACYTE, INC.

FiledFormInsiderReported transactionsSource
2026-10-294Wygant Jonathan — VP, Chief Accounting OfficerTax withholding (F): 1,306 @ $50.31EDGAR
2026-10-284EASTHAM KARIN — DirectorOption exercise (M): 10,000 @ $27.01 · Sale (S): 14,850 @ $50.00 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-10-284Holstein Jens — DirectorOption exercise (M): 7,500 @ $35.30 · Sale (S): 7,500 @ $47 · Option exercise (M): 7,500 @ $35.30 · Sale (S): 7,500 @ $50 · Option exercise (M): 7,500 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2026-10-204Bhanji Muna — DirectorSale (S): 1,864 @ $43.70EDGAR
2026-09-224Leite John — Global Chief Commercial OffSale (S): 4,015 @ $40EDGAR
2026-09-164Holstein Jens — DirectorSale (S): 5,000 @ $40.95EDGAR
2026-09-044Stapley Marc — Chief Executive Officer, DirectorTax withholding (F): 8,782 @ $44.88EDGAR
2026-09-044McGuire Annie — EVP, General CounselTax withholding (F): 3,215 @ $44.88 · Sale (S): 2,154 @ $42.79 · Sale (S): 1,100 @ $43.67EDGAR
2026-09-044Chambers Rebecca — Chief Financial OfficerTax withholding (F): 3,603 @ $44.88 · Sale (S): 2,477 @ $42.81 · Sale (S): 1,175 @ $43.71EDGAR
2026-09-044Febbo Phillip G. — Chief Scientific & Med OfficerTax withholding (F): 3,639 @ $44.88 · Sale (S): 10,405 @ $42.89 · Sale (S): 2,705 @ $43.66EDGAR
2026-09-044Leite John — Global Chief Commercial OffTax withholding (F): 3,961 @ $44.88EDGAR
2026-09-044Wygant Jonathan — VP, Chief Accounting OfficerTax withholding (F): 1,361 @ $44.88EDGAR
2026-09-034Bhanji Muna — DirectorSale (S): 1,864 @ $42.97EDGAR
2026-06-224EASTHAM KARIN — DirectorSale (S): 3,200 @ $52.78 · Sale (S): 529 @ $53.55EDGAR
2026-06-154Miller Thomas F. — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154Barr Eliav — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154Bhanji Muna — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154Holstein Jens — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154Shafer David Brent — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154EPSTEIN ROBERT S — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154EASTHAM KARIN — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-154JONES EVAN/ FA — DirectorGrant/award (A): 5,272 @ $0EDGAR
2026-06-044Leite John — Global Chief Commercial OffTax withholding (F): 4,059 @ $47.80 · Sale (S): 13,975 @ $50.07EDGAR
2026-06-044McGuire Annie — EVP, General CounselTax withholding (F): 3,292 @ $47.80 · Sale (S): 1,400 @ $49.31 · Sale (S): 1,776 @ $50.12EDGAR
2026-06-044Chambers Rebecca — Chief Financial OfficerTax withholding (F): 3,693 @ $47.80 · Sale (S): 1,600 @ $49.28 · Sale (S): 1,961 @ $50.09EDGAR
2026-06-044Febbo Phillip G. — Chief Scientific & Med OfficerTax withholding (F): 3,730 @ $47.80EDGAR
2026-06-044Wygant Jonathan — VP, Chief Accounting OfficerTax withholding (F): 1,361 @ $47.80EDGAR
2026-06-044Stapley Marc — Chief Executive Officer, DirectorTax withholding (F): 9,012 @ $47.80 · Option exercise (M): 138,051 @ $36.60 · Sale (S): 138,051 @ $50.12 · Option exercise (M): 138,051 (derivative) @ $0EDGAR
2026-05-274Wygant Jonathan — VP, Chief Accounting OfficerOption exercise (M): 24,000 @ $24.80 · Sale (S): 24,000 @ $45.40 · Option exercise (M): 24,000 (derivative) @ $0EDGAR
2026-05-224EPSTEIN ROBERT S — DirectorSale (S): 10,000 @ $44.01EDGAR
2026-05-084McGuire Annie — SVP, General CounselSale (S): 5,102 @ $38.05 · Sale (S): 5,102 @ $40EDGAR
2026-04-144Haas Kevin Richard — Chief Dev and Tech OfficerGrant/award (A): 44,221 @ $0EDGAR
2026-03-104Leite John — Chief Commercial Officer-CLIAGrant/award (A): 36,181 @ $0 · Grant/award (A): 6,578 @ $0EDGAR
2026-03-104McGuire Annie — SVP, General CounselGrant/award (A): 32,892 @ $0 · Grant/award (A): 26,314 @ $0EDGAR
2026-03-104Chambers Rebecca — Chief Financial OfficerGrant/award (A): 36,181 @ $0 · Grant/award (A): 13,157 @ $0EDGAR
2026-03-104Febbo Phillip G. — Chief Scientific & Med OfficerGrant/award (A): 29,603 @ $0 · Grant/award (A): 6,578 @ $0EDGAR
2026-03-104Wygant Jonathan — VP, Chief Accounting OfficerGrant/award (A): 10,525 @ $0EDGAR
2026-03-104Stapley Marc — Chief Executive Officer, DirectorGrant/award (A): 92,099 @ $0EDGAR
2026-03-064Leite John — Chief Commercial Officer-CLIASale (S): 5,260 @ $35.19EDGAR
2026-03-064McGuire Annie — SVP, General CounselSale (S): 4,994 @ $35.29 · Sale (S): 1,664 @ $36.34EDGAR
2026-03-064Chambers Rebecca — Chief Financial OfficerSale (S): 4,400 @ $35.55 · Sale (S): 13,941 @ $36.33EDGAR
2026-03-064Stapley Marc — Chief Executive Officer, DirectorSale (S): 19,244 @ $35.56 · Sale (S): 26,279 @ $36.28EDGAR
2026-03-044Leite John — Chief Commercial Officer-CLIATax withholding (F): 7,517 @ $36.01EDGAR
2026-03-044McGuire Annie — SVP, General CounselTax withholding (F): 6,902 @ $36.01EDGAR
2026-03-044Chambers Rebecca — Chief Financial OfficerTax withholding (F): 7,234 @ $36.01EDGAR
2026-03-044Febbo Phillip G. — Chief Scientific & Med OfficerTax withholding (F): 6,035 @ $36.01 · Sale (S): 13,425 @ $36.16EDGAR
2026-03-044Wygant Jonathan — VP, Chief Accounting OfficerTax withholding (F): 3,006 @ $36.01EDGAR
2026-03-044Stapley Marc — Chief Executive Officer, DirectorTax withholding (F): 19,455 @ $36.01EDGAR
2026-03-024Febbo Phillip G. — Chief Scientific & Med OfficerGrant/award (A): 71,806 @ $0 · Tax withholding (F): 24,486 @ $38.75EDGAR
2026-03-024Stapley Marc — Chief Executive Officer, DirectorGrant/award (A): 139,074 @ $0 · Tax withholding (F): 35,841 @ $38.75EDGAR

Recent 8-K events — VERACYTE, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2026-05-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-02-258-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VCYT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs